All Stories

  1. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson’s Disease: Pulsatile versus Continuous Dopaminergic Stimulation
  2. Levodopa after 60 years: still a gold standard drug, with so many formulations to use.
  3. Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients
  4. Morning akinesia in Parkinson's disease: challenges and solutions
  5. Imaging synucleinopathies
  6. Prognostic factors in children with PRES and hematologic diseases
  7. CSF levels of heart fatty acid binding protein in Parkinson's and Alzheimer's disease
  8. Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism
  9. The validation of an Italian version of the Freezing of Gait Questionnaire
  10. Diagnostic Accuracy of Parkinson Disease by Support Vector Machine (SVM) Analysis of 123I-FP-CIT Brain SPECT Data
  11. Subclinical Visuospatial Impairment in Parkinson’s Disease: The Role of Basal Ganglia and Limbic System
  12. Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome
  13. Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
  14. Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study
  15. Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
  16. Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease
  17. Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study
  18. Cerebrospinal fluid biomarkers in Parkinson disease
  19. The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients
  20. Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale
  21. Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson’s Disease Patients
  22. Clinical Aspects and Management of Levodopa-Induced Dyskinesia
  23. Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease
  24. CFS Biomarkers in Parkinson’s Disease
  25. Recurrent hypothermia with hyperhidrosis in two siblings: familial Shapiro syndrome variant
  26. Levodopa-induced breathing, cognitive and behavioral changes in Parkinson’s disease
  27. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
  28. Levetiracetam in brain ischemia: Clinical implications in neuroprotection and prevention of post-stroke epilepsy
  29. Decreased Contralateral Putamen [123I]FP-CIT SPECT Uptake in Hyperglycemic Hemichorea-Hemiballismus
  30. Ictal Epileptic Headache Mimicking Status Migrainosus: EEG and DWI-MRI Findings
  31. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
  32. Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis
  33. Vomiting due to intravenous levetiracetam in a case of Creutzfeldt–Jakob disease
  34. A young patient with type C multiple system atrophy and hereditary hemochromatosis
  35. Hot water epilepsy and Mccune–Albright syndrome: A case report
  36. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy
  37. Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
  38. Nerve growth factor and brain-derived neurotrophic factor: potential targets for migraine treatment?
  39. Acute dystonia induced by the combination of midodrine and perphenazine
  40. Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide
  41. Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease
  42. Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: Results of a population-based study
  43. Characteristics of Delayed Admission to Stroke Unit
  44. Efficacy of Thrombolytic (rt-PA) Therapy in Old Stroke Patients: The Perugia Stroke Unit Experience
  45. Multimodal Use of Computed Tomography in Early Acute Stroke, Part 1
  46. Cardiac pacing: atrial fibrillation may go unrecognised
  47. A case of vertebrobasilar stroke during oxygen-ozone therapy
  48. BRAIN CT-SCAN IN ACUTE STROKE PATIENTS: SILENT INFARCTS AND RELATION TO OUTCOME
  49. BRAIN CT SCAN IN ACUTE ISCHEMIC STROKE: EARLY SIGNS AND FUNCTIONAL OUTCOME